We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Updated: 1/10/2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Raspberries and Postprandial Metabolism
Updated: 1/10/2018
Raspberries, Postprandial Metabolism and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Raspberries and Postprandial Metabolism
Updated: 1/10/2018
Raspberries, Postprandial Metabolism and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Updated: 1/11/2018
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Status: Enrolling
Updated: 1/11/2018
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Updated: 1/11/2018
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Updated: 1/11/2018
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Updated: 1/12/2018
The Effect of a Long-term Medium Chain Supplemented Diet on Cognitive Function and Brain Activation During Hypoglycemia in Type 1 Diabetes.
Status: Enrolling
Updated: 1/12/2018
Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Updated: 1/12/2018
The Effect of a Long-term Medium Chain Supplemented Diet on Cognitive Function and Brain Activation During Hypoglycemia in Type 1 Diabetes.
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
AbATE Follow-Up Study
Updated: 1/12/2018
ITN0127AI Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes (AbATE) Follow-Up Study
Status: Enrolling
Updated: 1/12/2018
AbATE Follow-Up Study
Updated: 1/12/2018
ITN0127AI Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes (AbATE) Follow-Up Study
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Updated: 1/12/2018
Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake
Status: Enrolling
Updated: 1/12/2018
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Updated: 1/12/2018
Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials